ACA
YARW

Acorn Capital Advisors’s Yarrow Bioscience YARW Stock Holding History

Acorn Capital Advisors’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$926 Hold
29
– – ﹤0.01% 20
2026
Q1 		$855 Hold
29
– – ﹤0.01% 22
2025
Q4 		$827 Sell
29
-11,702
-100% -$235K ﹤0.01% 21
2025
Q3 		$199K Sell
11,731
-3,000
-20% -$98.1K 0.1% 20
2025
Q2 		$1.22M Sell
14,731
-988
-6% -$64.2K 0.79% 18
2025
Q1 		$1.24M Buy
15,719
+6,580
+72% +$810K 0.83% 21
2024
Q4 		$1.53M Buy
+9,139
New +$1.2M 0.82% 20

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Acorn Capital Advisors's YARW Position: Q2 2026 in Review

Acorn Capital Advisors held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 29 shares worth $926. The position accounts for ﹤0.01% of the portfolio, ranked #20.

Acorn Capital Advisors first reported a position in YARW in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.53M in Q4 2024. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Acorn Capital Advisors held 29 shares of Yarrow Bioscience worth $926 as of Q2 2026.
  • Acorn Capital Advisors left its Yarrow Bioscience share count unchanged in Q2 2026.
  • Yarrow Bioscience made up ﹤0.01% of Acorn Capital Advisors's portfolio in Q2 2026, its #20 holding.
  • Acorn Capital Advisors first reported a position in Yarrow Bioscience in Q4 2024 and has held it in 7 quarters since.
  • Acorn Capital Advisors's Yarrow Bioscience position peaked at $1.53M in Q4 2024.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Acorn Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.